Hideki Kakeya
Biographic Data
| ID | 9996673 |
|---|---|
| NAME | Hideki Kakeya |
| GIVEN NAMES | Hideki |
| FAMILY NAME | Kakeya |
| SIGNATURE | KAKEYA H |
| AFFILIATIONS | University of Tsukuba |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Persistent excess mortality in post-pandemic Japan
More than six years after the emergence of COVID-19, Japan continues to experience persistently elevated excess mortality despite entering a post-pandemic phase. Excess mortality, defined as the difference between observed and expected deaths, reflects both direct and indirect effects of the pandemic, including healthcare disruption, delayed care, and broader social changes. In Japan, mortality decreased slightly in 2020 but increased markedly fr…
Age-specific patterns of all-cause mortality across Covid-19 booster dose groups in two Japanese municipalities
Background/purpose: COVID-19 mRNA vaccines have been reported to reduce severe COVID-19 outcomes in high-risk populations. In Japan, booster vaccinations up to the seventh dose are publicly funded; however, evidence regarding the safety and potential benefits of repeated booster doses in younger adults remains limited. This exploratory observational study aimed to describe age-specific patterns of all-cause mortality according to the number of CO…
No prominent works on this page.
Persistent excess mortality in post-pandemic Japan
More than six years after the emergence of COVID-19, Japan continues to experience persistently elevated excess mortality despite entering a post-pandemic phase. Excess mortality, defined as the difference between observed and expected deaths, reflects both direct and indirect effects of the pandemic, including healthcare disruption, delayed care, and broader social changes. In Japan, mortality decreased slightly in 2020 but increased markedly fr…
Age-specific patterns of all-cause mortality across Covid-19 booster dose groups in two Japanese municipalities
Background/purpose: COVID-19 mRNA vaccines have been reported to reduce severe COVID-19 outcomes in high-risk populations. In Japan, booster vaccinations up to the seventh dose are publicly funded; however, evidence regarding the safety and potential benefits of repeated booster doses in younger adults remains limited. This exploratory observational study aimed to describe age-specific patterns of all-cause mortality according to the number of CO…
Observational study (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Vaccination (2 works) · Age groups (1 works) · Booster dose (1 works) · COVID-19 and healthcare impacts (1 works) · COVID-19 Clinical Research Studies (1 works) · Excess mortality (1 works) · Exploratory analysis (1 works) · Health care (1 works)